From: CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
Clinical characteristics | Patients (n = 120) | CD146 High | CD146 low | P value |
---|---|---|---|---|
Age(Y) | ≥ 50 | 41 | 42 |  |
 | < 50 | 17 | 20 | 0.727 |
Sex | Male | 52 | 54 | Â |
 | Female | 6 | 8 | 0.663 |
HBsAg | Positive | 51 | 60 | Â |
 | Negative | 7 | 2 | 0.136a |
Child-Pugh score | A | 56 | 61 | Â |
 | B | 2 | 1 | 0.953a |
Liver cirrhosis | Yes | 51 | 57 | Â |
 | No | 7 | 5 | 0.465 |
AFP (ng/ml) | ≥ 400 | 39 | 27 |  |
 | < 400 | 19 | 35 | 0.009 |
Tumor number | single | 45 | 51 | Â |
 | multiple | 13 | 11 | 0.523 |
Tumor size (cm) | ≥ 5 | 42 | 43 |  |
 | < 5 | 16 | 19 | 0.713 |
Vascular invasion | Yes | 24 | 13 | Â |
 | No | 34 | 49 | 0.016 |
Satellite lesion | Yes | 13 | 5 | Â |
 | No | 45 | 57 | 0.028 |
Tumor encapsulation | Complete | 27 | 42 | Â |
 | None | 31 | 20 | 0.019 |
Edmondson stage | I-II | 20 | 37 | Â |
 | III-IV | 38 | 25 | 0.006 |
Recurrence | Yes | 47 | 23 | Â |
 | No | 11 | 39 | <0.001 |